Montreal-based Puzzle Medical has secured $30.15 million (CAN$43 million) in a funding round led by KF Matheson and Desjardins Capital, with support from Lumira Ventures, Longview Ventures, BDC Capital, and returning investors. This brings the company’s total raised to over $55 million.
What the funds will support:
- Refinement of its modular, percutaneous heart pump
- Advancement of clinical trials
- Team expansion to fuel growth and commercialization
The startup’s heart pump offers a less-invasive alternative to LVADs, anchoring 4mm pumps in the descending aorta to support both cardiac and renal function. Designed for patients with advanced heart failure, it aims to enhance quality of life with long-term use and reduced procedural complexity.
“This funding is a true testament to the impact of our work,” said Jade Doucet-Martineau, CEO and co-founder.
Follow MEDWIRE.AI for cardiovascular device funding and innovation updates.
